vs

Side-by-side financial comparison of Copart (CPRT) and Zimmer Biomet (ZBH). Click either name above to swap in a different company.

Zimmer Biomet is the larger business by last-quarter revenue ($2.1B vs $1.2B, roughly 1.8× Copart). Copart runs the higher net margin — 35.0% vs 11.4%, a 23.5% gap on every dollar of revenue. On growth, Zimmer Biomet posted the faster year-over-year revenue change (9.3% vs 0.7%). Copart produced more free cash flow last quarter ($427.2M vs $245.9M). Over the past eight quarters, Copart's revenue compounded faster (6.4% CAGR vs 3.7%).

Copart, Inc. is a multinational provider of online vehicle auction and remarketing services to automotive resellers such as insurance, rental car, fleet, and finance companies in 11 countries: the US, Canada, the UK, Germany, Ireland, Brazil, Spain, UAE, Bahrain, Oman, and Finland. Headquartered in Dallas, Texas, Copart has more than 200 physical locations, where it houses more than 10,000 acres of vehicle inventory.

Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.

CPRT vs ZBH — Head-to-Head

Bigger by revenue
ZBH
ZBH
1.8× larger
ZBH
$2.1B
$1.2B
CPRT
Growing faster (revenue YoY)
ZBH
ZBH
+8.6% gap
ZBH
9.3%
0.7%
CPRT
Higher net margin
CPRT
CPRT
23.5% more per $
CPRT
35.0%
11.4%
ZBH
More free cash flow
CPRT
CPRT
$181.3M more FCF
CPRT
$427.2M
$245.9M
ZBH
Faster 2-yr revenue CAGR
CPRT
CPRT
Annualised
CPRT
6.4%
3.7%
ZBH

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CPRT
CPRT
ZBH
ZBH
Revenue
$1.2B
$2.1B
Net Profit
$403.7M
$238.3M
Gross Margin
64.6%
Operating Margin
37.3%
17.9%
Net Margin
35.0%
11.4%
Revenue YoY
0.7%
9.3%
Net Profit YoY
11.5%
30.5%
EPS (diluted)
$0.41
$1.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CPRT
CPRT
ZBH
ZBH
Q1 26
$2.1B
Q4 25
$1.2B
$2.2B
Q3 25
$1.1B
$2.0B
Q2 25
$1.2B
$2.1B
Q1 25
$1.2B
$1.9B
Q4 24
$1.1B
$2.0B
Q3 24
$1.1B
$1.8B
Q2 24
$1.1B
$1.9B
Net Profit
CPRT
CPRT
ZBH
ZBH
Q1 26
$238.3M
Q4 25
$403.7M
$139.4M
Q3 25
$396.4M
$230.9M
Q2 25
$406.6M
$152.8M
Q1 25
$387.4M
$182.0M
Q4 24
$362.1M
$239.5M
Q3 24
$322.6M
$249.1M
Q2 24
$382.3M
$242.8M
Gross Margin
CPRT
CPRT
ZBH
ZBH
Q1 26
64.6%
Q4 25
64.7%
Q3 25
72.1%
Q2 25
71.5%
Q1 25
71.2%
Q4 24
71.0%
Q3 24
70.5%
Q2 24
71.5%
Operating Margin
CPRT
CPRT
ZBH
ZBH
Q1 26
17.9%
Q4 25
37.3%
6.9%
Q3 25
36.7%
17.6%
Q2 25
37.3%
14.4%
Q1 25
36.6%
15.3%
Q4 24
35.4%
19.2%
Q3 24
33.6%
15.3%
Q2 24
38.8%
18.1%
Net Margin
CPRT
CPRT
ZBH
ZBH
Q1 26
11.4%
Q4 25
35.0%
6.2%
Q3 25
35.2%
11.5%
Q2 25
33.6%
7.4%
Q1 25
33.3%
9.5%
Q4 24
31.6%
11.8%
Q3 24
30.2%
13.7%
Q2 24
33.9%
12.5%
EPS (diluted)
CPRT
CPRT
ZBH
ZBH
Q1 26
$1.22
Q4 25
$0.41
$0.71
Q3 25
$0.40
$1.16
Q2 25
$0.42
$0.77
Q1 25
$0.40
$0.91
Q4 24
$0.37
$1.18
Q3 24
$0.34
$1.23
Q2 24
$0.39
$1.18

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CPRT
CPRT
ZBH
ZBH
Cash + ST InvestmentsLiquidity on hand
$424.2M
Total DebtLower is stronger
$7.5B
Stockholders' EquityBook value
$9.6B
$12.7B
Total Assets
$10.6B
$22.7B
Debt / EquityLower = less leverage
0.59×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CPRT
CPRT
ZBH
ZBH
Q1 26
$424.2M
Q4 25
$591.9M
Q3 25
$1.3B
Q2 25
$556.9M
Q1 25
$1.4B
Q4 24
$525.5M
Q3 24
$569.0M
Q2 24
$420.1M
Total Debt
CPRT
CPRT
ZBH
ZBH
Q1 26
$7.5B
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$0
Q2 24
$427.0K
Stockholders' Equity
CPRT
CPRT
ZBH
ZBH
Q1 26
$12.7B
Q4 25
$9.6B
$12.7B
Q3 25
$9.2B
$12.8B
Q2 25
$8.8B
$12.5B
Q1 25
$8.3B
$12.4B
Q4 24
$7.9B
$12.5B
Q3 24
$7.5B
$12.4B
Q2 24
$7.2B
$12.7B
Total Assets
CPRT
CPRT
ZBH
ZBH
Q1 26
$22.7B
Q4 25
$10.6B
$23.1B
Q3 25
$10.1B
$23.5B
Q2 25
$9.7B
$22.9B
Q1 25
$9.2B
$22.2B
Q4 24
$8.9B
$21.4B
Q3 24
$8.4B
$21.7B
Q2 24
$8.0B
$21.5B
Debt / Equity
CPRT
CPRT
ZBH
ZBH
Q1 26
0.59×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.00×
Q2 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CPRT
CPRT
ZBH
ZBH
Operating Cash FlowLast quarter
$535.3M
$359.4M
Free Cash FlowOCF − Capex
$427.2M
$245.9M
FCF MarginFCF / Revenue
37.0%
11.8%
Capex IntensityCapex / Revenue
9.4%
Cash ConversionOCF / Net Profit
1.33×
1.51×
TTM Free Cash FlowTrailing 4 quarters
$1.4B
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CPRT
CPRT
ZBH
ZBH
Q1 26
$359.4M
Q4 25
$535.3M
$517.4M
Q3 25
$438.5M
$418.7M
Q2 25
$700.9M
$378.2M
Q1 25
$178.1M
$382.8M
Q4 24
$482.3M
$506.3M
Q3 24
$439.2M
$395.7M
Q2 24
$496.3M
$369.4M
Free Cash Flow
CPRT
CPRT
ZBH
ZBH
Q1 26
$245.9M
Q4 25
$427.2M
$442.6M
Q3 25
$350.8M
$363.7M
Q2 25
$572.9M
$328.1M
Q1 25
$61.5M
$338.2M
Q4 24
$245.5M
$454.8M
Q3 24
$301.3M
$351.2M
Q2 24
$408.5M
$316.7M
FCF Margin
CPRT
CPRT
ZBH
ZBH
Q1 26
11.8%
Q4 25
37.0%
19.7%
Q3 25
31.2%
18.2%
Q2 25
47.3%
15.8%
Q1 25
5.3%
17.7%
Q4 24
21.4%
22.5%
Q3 24
28.2%
19.3%
Q2 24
36.2%
16.3%
Capex Intensity
CPRT
CPRT
ZBH
ZBH
Q1 26
Q4 25
9.4%
3.3%
Q3 25
7.8%
2.7%
Q2 25
10.6%
2.4%
Q1 25
10.0%
2.3%
Q4 24
20.6%
2.5%
Q3 24
12.9%
2.4%
Q2 24
7.8%
2.7%
Cash Conversion
CPRT
CPRT
ZBH
ZBH
Q1 26
1.51×
Q4 25
1.33×
3.71×
Q3 25
1.11×
1.81×
Q2 25
1.72×
2.48×
Q1 25
0.46×
2.10×
Q4 24
1.33×
2.11×
Q3 24
1.36×
1.59×
Q2 24
1.30×
1.52×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CPRT
CPRT

Services$952.1M82%
Other$203.0M18%

ZBH
ZBH

Segment breakdown not available.

Related Comparisons